Blum S*, Zlotoff D*, Smith NP*, Kernin I, …Thomas MF**, Neilan T**, Reynolds KL**, and Villani AC**. Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor. BioRxiv DOI:10.1101/2023.09.15.557794 (2023). *Equal contribution **Senior Author
LaSalle TJ, Gonye ALK, Freeman SS, Kaplonek P, Gushterova I, Kays KR, Manakongtreecheep K, Tantivit J, Rojas-Lopez M, Russo BC, Sharma N, Thomas MF...Villani AC, Hacohen N, Sade-Feldman M. Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with severity in hospitalized COVID-19 patients. Cell Rep Med. 3(10):100779 (2022). PMCID: PMC9510054.
Thomas MF*, Slowikowski K*...Hacohen N, Reynolds KL, Li B, and Villani AC. Altered interactions between circulating and tissue-resident CD8 T cells with the colonic mucosa define colitis associated with immune checkpoint inhibitors. bioRxiv doi: 10.1101/2021.09.17.460868 (2021). *Equal contribution
Galván-Peña S, Leon J, Chowdhary K…Thomas MF, Mathis D, Benoist C. Profound Treg perturbations correlate with COVID-19 severity. PNAS. 118(37) (2021) PMCID: PMC8449354.
Zubiri L, Molina G, Mooradian MJ, Cohen J, Durbin S, Petrillo L, Boland G, Juric D, Dougan M, Thomas MF…Villani AC, and Reynolds KL. Effect of a Multidisciplinary Severe Immunotherapy Complication Service on Outcomes for Patients Receiving Immune Checkpoint Inhibitor Therapy for Cancer. The Journal for ImmunoTherapy of Cancer, Sep;9(9): e002886 (2021). PMID 34544895.
Molina GE, Zubiri L, Cohen JV, Durbin SM, Petrillo L, Allen IM, Murciano-Goroff YR, Dougan M, Thomas MF…Villani AC, Reynolds KL. Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018. The Oncologist. 26(6): 514-522 (2021). PMID: 33655682.
Reynolds K, Thomas MF, Dougan M. Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade. The Oncologist, Sep; 23(9): 991-997 (2018). PMID 29853659.
Thomas MF, L’Etoile N, and KM Ansel. Eri1: A conserved enzyme at the crossroads of multiple RNA-processing pathways. Trends in Genetics, 30(7): 298-307 (2014). PMID: 24929628.
Thomas MF, Abdul–Wajid S, Panduro M, Babiarz JE, Rajaram M, Woodruff P, Lanier LL, Heissmeyer V and KM Ansel. Eri1 regulates microRNA homeostasis and mouse lymphocyte development and antiviral function. Blood. 120(1): 130–142 (2012). PMID 22613798.
Steiner DF, Thomas MF, Hu JK, Yang Z, Babiarz JE, Allen CD, Matloubian M, Blelloch R, and KM Ansel. MicroRNA–29 regulates T–box transcription factors and IFN–γ production in helper T cells. Immunity. 35(2): 169–81 (2011). PMID 21820330.
Thomas MF & KM Ansel. Construction of small RNA cDNA libraries for deep sequencing. In Methods in Molecular Biology: MicroRNAs and the Immune System, Vol. 667, ed. Monticelli, S. Humana Press Inc. (2010). PMID 20827529.